batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Schrödinger pipeline shrinks to two clinical assets 14 August 2025 CytomX has a tox wobble 13 August 2025 Kumquat’s KRAS blocker tempts Bayer 12 August 2025 Keytruda and Padcev make early bladder cancer bid 12 August 2025 Novartis scores a Vayhit, but filing some way off 12 August 2025 Tricky mechanisms fall by the wayside 11 August 2025 Epkinly bucks the delay trend 11 August 2025 Arcus reaches the end of the road for etrumadenant 7 August 2025 Load More